SLC1A2 and nervous system disorder: GLT1 is expressed primarily in astrocytes and has been shown to be expressed in axon terminals of neurons20–22, and its dysregulation occurs in various neurological diseases including Huntington’s disease, Alzheimer’s disease, Parkinson’s disease, epilepsy, and ALS23–26.